DNM1L and neoplasm: Targeting DRP1-dependent mitochondrial fission by siRNA knockdown or treatment with Mdivi-1 can significantly induce HCC cells arrest to reduce tumor growth2, attenuate lipid metabolism to reduce hepatocarcinogenesis40, and even improve the antitumor capacity of NK cells41.